| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.33 | 9e-06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |